Related Experiment Video
Updated: May 29, 2026

Assessment of Vascular Function in Patients With Chronic Kidney Disease
Published on: June 16, 2014
What are the differences between younger and older patients with symptomatic small vessel disease?
Aleksandra M Pavlović1, Tatjana Pekmezović, Jasna Zidverc-Trajković
1Clinic for Neurology, Clinical Center of Serbia, Faculty of Medicine, University of Belgrade, Belgrade, Serbia. aleksandrapavlovic@hotmail.com
Objective:
Although typically linked to aging, small vessel disease (SVD) is also observed in younger adult patients, with common vascular risk factors (RF). We aimed to investigate features of SVD occurrence at an early adult age.
Patients And Methods:
Vascular RF, functional and cognitive status and severity of lesions on MRI expressed as total score on Age-Related White Matter Changes (ARWMC) scale were analyzed in 200 consecutive patients with cerebral SVD admitted to a tertiary neurological hospital. Variables were compared between younger (35-55 years) and older (>56 years) patients.
Results:
In this study, 63 (31.5%) of patients were 55 years or younger. Both age groups had comparable RF profiles, but smoking emerged as an independent predictor for SVD at a younger age (OR 2.9; 95% CI 1.5-5.5; p=0.002). Younger patients had better functional (OR 1.8; 95% CI 1.3-2.5; p=0.0001) and cognitive (χ(2) 13.94; p=0.0009) status compared to older patients. However, two thirds of younger patients had some degree of cognitive deficit. Total score on ARWMC scale was lower in younger patients (mean 12.3 in younger versus 15.2 in older, OR 1.11; 95% CI 1.0-1.18; p=0.001). There was a strong correlation in both groups between functional score, cognitive status and ARWMC score (p<0.0001).
Conclusion:
In our dataset, younger patients with SVD shared common vascular RF with older patients. In the group aged ≤55, better functional and cognitive status and less severe MRI changes were noted. However, a substantial number of younger SVD patients presenting with TIA or ischemic stroke had various deficits.
Insights
Small vessel disease (SVD) affects younger adults, with smoking as a key risk factor. While younger patients show better function and cognition, many still experience deficits, highlighting the need for early intervention.
Area of Science:
- Neurology
- Vascular Neurology
- Neuroimaging
Background:
- Small vessel disease (SVD) is typically associated with aging.
- However, SVD can occur in younger adults, often linked to vascular risk factors.
- Understanding early-onset SVD is crucial for timely diagnosis and management.
Purpose of the Study:
- To investigate the characteristics of small vessel disease (SVD) in early adult patients.
- To compare features of SVD between younger (35-55 years) and older (>56 years) patient groups.
Main Methods:
- Analysis of 200 consecutive patients with cerebral SVD.
- Assessment of vascular risk factors, functional and cognitive status.
- Evaluation of SVD severity using the Age-Related White Matter Changes (ARWMC) scale on MRI.
Main Results:
- Smoking was an independent predictor of SVD in younger patients (OR 2.9).
- Younger patients exhibited better functional and cognitive status but still had deficits in two-thirds.
- Lower ARWMC scores were observed in younger patients, correlating with better functional and cognitive outcomes.
Conclusions:
- Younger SVD patients share vascular risk factors with older counterparts.
- Early-onset SVD is associated with better functional and cognitive status and less severe MRI changes.
- Despite better outcomes, a significant proportion of younger SVD patients experience deficits, underscoring the importance of early detection.
Related Concept Videos
Pharmacodynamics in Geriatric Patients: Effects of Age
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Drug Dosing: Geriatric Patients
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

